Sotyktu Bridge Program

Funded
About
The Sotyktu Bridge Program offers a valuable opportunity for patients prescribed the drug Sotyktu. Providing up to 36 months of free medication for eligible commercially insured patients, this program ensures access to Sotyktu until insurance coverage is secured. With requirements like insurance approval and periodic eligibility verification, the Sotyktu Bridge Program aims to support patients through their treatment with Sotyktu efficiently.
Insurance requirements: Commercially insured
Enrollment Forms
Enrollment Form
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: No
Activation Required: No
Program Details
Eligible commercially insured patients may receive free medication for up to 36 months (up to 12 months coverage for residents in Massachusetts, Minnesota, and Rhode Island) until the patient's insurance covers the medication
Appeal of any prior authorization denial must be made within 90 days or as per payer guidelines, to remain in the Program
Eligibility will be reverified on a rolling 12month basis from the patient’s first shipment date, and may be reverified at other times during Program participation
Medication will be dispensed in 30day prescriptions
For additional information contact the program at 8887689588
Other Programs

Assistance Fund: Psoriasis

Coverage Required
Commercially Insured
Medicare / Medicaid

Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF)

Medicare / Medicaid
Underinsured
Uninsured
Pay as low as
$0/ fill
Other Tools for Sotyktu